Live Breaking News & Updates on Michelle Laspaluto

Stay updated with breaking news from Michelle laspaluto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

– ONC201 ACTION Study Progressing; Reiterate Interim OS Data Expected in 2025, Final OS Data Expected in 2026 – ....

United States , Lisa Decker , Pablo Lee , Mike Andriole , American Society Of Clinical Oncology , National Institutes Of Health , Oncology Consortium , Exchange Commission , Reiterate Interim , Peer Reviewed Journal , Clinical Oncology , Conference Call , Chief Executive Officer , Michelle Laspaluto , Chief Financial Officer , Tom Riga , Chief Operating , Commercial Officer , Vice President , Diffuse Midline Glioma , American Society , Response Assessment , National Institutes , Pacific Pediatric Neuro Oncology Consortium , Emergent Biosolutions , Private Securities Litigation Reform Act ,

Chimerix Reports Fourth Quarter And Year End 2023 Financial Results And Provides Operational Update

Chimerix Reports Fourth Quarter And Year End 2023 Financial Results And Provides Operational Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United States , Mike Andriole , Lisa Decker , Pablo Lee , National Institutes Of Health , American Society Of Clinical Oncology , Oncology Consortium , Exchange Commission , Reiterate Interim , Peer Reviewed Journal , Clinical Oncology , Conference Call , Chief Executive Officer , Michelle Laspaluto , Chief Financial Officer , Tom Riga , Chief Operating , Commercial Officer , Vice President , Diffuse Midline Glioma , American Society , Response Assessment , National Institutes , Pacific Pediatric Neuro Oncology Consortium , Emergent Biosolutions , Private Securities Litigation Reform Act ,

Durham biotech Chimerix promotes exec to CFO

Durham-based biopharmaceutical Chimerix, has promoted Michelle LaSpaluto, current vice president of corporate financial planning and investor relations, to chief financial officer. ....

Michelle Laspaluto ,

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

DURHAM, N.C., Dec. 04, 2023 Chimerix , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today. ....

Mike Andriole , Michelle Laspaluto , Carolina University , Globenewswire Inc , Michigan State University , Chimerix Inc , Vice President , Corporate Financial Planning , Investor Relations , Chief Financial Officer , Chief Executive Officer , Vice President Corporate Financial Planning , Senior Director ,

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

DURHAM, N.C., Nov. 16, 2023 Chimerix , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today. ....

Mike Andriole , Eli Lilly , Michelle Laspaluto , Compensation Committee Of Chimerix Board Directors , Chimerix Inc , Exchange Commission , Lawrence University , Spectrum Pharmaceuticals , Globenewswire Inc , Chief Operating , Chief Executive Officer , Chief Commercial Officer , Chief Operating Officer , Ayerst Laboratories , Private Securities Litigation Reform Act , Compensation Committee , Incentive Plan , Nasdaq Listing Rule ,